Safety and Efficacy Study of Autologous Cultured Adipose -Derived Stem Cells for the Crohn's Fistula
NCT00992485
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
9
Enrollment
INDUSTRY
Sponsor class
Conditions
Crohn's Fistula
Interventions
DRUG:
ADIPOPLUS
Sponsor
Anterogen Co., Ltd.